These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9469030)

  • 21. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
    Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Potentiation of hydrocortisone by admixture of urea].
    Ernst TM
    Z Hautkr; 1980 Jun; 55(12):806-12. PubMed ID: 7415361
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms of action of topical therapies and the rationale for combination therapy.
    Norris DA
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S17-25. PubMed ID: 15968260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Local treatment of psoriasis vulgaris with prescription drugs].
    de la Brassinne M; Delattre L; Lorand T
    Rev Med Liege; 1983 Sep; 38(18):690-2. PubMed ID: 6648177
    [No Abstract]   [Full Text] [Related]  

  • 26. Concentration of an epidermal growth factor in blood serum of males during topical treatment of psoriasis.
    Pietrzak A; Miturski R; Krasowska D; Postawski K; Lecewicz-Toruń B
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):1-5. PubMed ID: 10188141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-specific differences in the treatment of severe psoriasis.
    Hotard RS; Feldman SR; Fleischer AB
    J Am Acad Dermatol; 2000 Apr; 42(4):620-3. PubMed ID: 10727307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticosteroids: options in the era of steroid-sparing therapy.
    Del Rosso J; Friedlander SF
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S50-8. PubMed ID: 15968264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of the efficacy of topical corticosteroid: five locally made and one brand name creams.
    Puavilai S; Krisadaphong P; Leenutaphong V; Asawanonda P; Akaraphan R; Ploysangham T; Ruangkarnchanasetr S; Noppakun N; Charuwichitratana S; Kulthanan K; Huiprasert P; Tresukosol P; Ophaswongse S
    J Med Assoc Thai; 2002 Jul; 85(7):789-99. PubMed ID: 12296411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
    Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
    J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comment on the letter and response regarding "Treatment of psoriasis capilliti with Dethranol].
    Ummenhofer B
    J Dtsch Dermatol Ges; 2004 Feb; 2(2):156. PubMed ID: 16279251
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of biologicals in psoriasis].
    Friedrich M; Philipp S; Sabat R; Asadullah K; Sterry W
    Z Rheumatol; 2003 Oct; 62(5):439-49. PubMed ID: 14579031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scalp psoriasis: a review of current topical treatment options.
    Papp K; Berth-Jones J; Kragballe K; Wozel G; de la Brassinne M
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1151-60. PubMed ID: 17894698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis.
    Miller JJ; Roling D; Margolis D; Guzzo C
    J Am Acad Dermatol; 1999 Oct; 41(4):546-9. PubMed ID: 10495373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated lip involvement in psoriasis.
    Baz K; Yazici AC; Usta A; Ikizoglu G; Apa DD
    Clin Exp Dermatol; 2007 Sep; 32(5):578-9. PubMed ID: 17501965
    [No Abstract]   [Full Text] [Related]  

  • 39. Topical glucocorticosteroids for psoriasis.
    Brookes DB; Seville RH
    Br Med J; 1978 Apr; 1(6119):1056. PubMed ID: 638607
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical glucocorticosteroids for psoriasis.
    Br Med J; 1978 Apr; 1(6116):855-6. PubMed ID: 638487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.